Janssen Sues Biosimilar Maker Celltrion Over its Remicade Manufacturing Patent

Janssen Biotech is suing Celltrion and Hospira in the latest of a series of lawsuits related to its blockbuster Remicade (infliximab) therapy.
Source: Drug Industry Daily